World's Best Scientists 2026 revealed!
Sylvie Ménard

Sylvie Ménard

D-Index & Metrics

Medicine

D-Index
84
Citations
31147
World Ranking
14949
National Ranking
583

Sylvie Ménard publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sylvie Ménard sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 436 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sylvie Ménard D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sylvie Ménard sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sylvie Ménard is affiliated with the University of Milan in Italy and has conducted research across multiple disciplines, including Medicine and Engineering. Their work spans subfields such as Ocean Engineering, Cancer Research, Surgery, Pathology and Forensic Medicine, and Radiological and Ultrasound Technology.

The scientist's research topics cover a range of areas with a particular focus on breast cancer and oil and gas production techniques. The main topics addressed in their work include:

  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • Oil and Gas Production Techniques
  • Occupational Health and Safety Research
  • Drilling and Well Engineering

Their recent publications feature two papers from 2024. One, published in the British Journal of Surgery, is titled "Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial." The other, appearing in the Offshore Technology Conference proceedings, is called "Enhancing Tubular Running Operations by Automation and Validating the Proof of Value in Well Construction Through an Intelligent and Autonomous Tong Solution."

These publications reflect an interdisciplinary approach that combines medical research on breast cancer treatment with applied engineering in offshore and well construction technologies.

Collaborative efforts are noted with several frequent co-authors, which include:

  • Roberto Agresti
  • Marco Sandri
  • Giuseppe Capri
  • Giulia Bianchi
  • Tiziana Triulzi

Their work has been disseminated primarily through venues such as the British Journal of Surgery and the Offshore Technology Conference, indicating a balance between clinical medical studies and technical engineering research.

Best Publications

  • MicroRNA gene expression deregulation in human breast cancer.

    Marilena V. Iorio;Manuela Ferracin;Chang Gong Liu;Angelo Veronese

  • MicroRNA Signatures in Human Ovarian Cancer

    Carlo M. Croce

  • Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2.

    Roberto Gennari;Sylvie Menard;Francesco Fagnoni;Luisa Ponchio

  • Biologic and therapeutic role of HER2 in cancer.

    Sylvie Ménard;Serenella Marja Pupa;Manuela Campiglio;Elda Tagliabue

  • Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy

    Valentina Ciravolo;Veronica Huber;Gaia C. Ghedini;Elisabetta Venturelli

  • Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity

    S. Miotti;S. Canevari;S. Ménard;D. Mezzanzanica

  • High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.

    Mary L. Disis;Serenella M. Pupa;Julie R. Gralow;Ruggero Dittadi

  • Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

    A. Bergamaschi;E. Tagliabue;Therese Sorlie;Therese Sorlie;Bjorn Naume

  • New insights into the role of extracellular matrix during tumor onset and progression.

    Serenella M. Pupa;Sylvie Ménard;Stefania Forti;Elda Tagliabue

  • microRNA-205 Regulates HER3 in Human Breast Cancer

    Marilena V. Iorio;Patrizia Casalini;Claudia Piovan;Gianpiero Di Leva

  • Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis

    Francesco Pezzella;Ugo Pastorino;Elda Tagliabue;Salvatore Andreola

  • Role of HER2 gene overexpression in breast carcinoma.

    Sylvie Ménard;Elda Tagliabue;Manuela Campiglio;Serenella M. Pupa

  • A Comparative Study of p53 Gene Mutations, Protein Accumulation, and Response to Cisplatin-based Chemotherapy in Advanced Ovarian Carcinoma

    S C Righetti;G Della Torre;S Pilotti;S Ménard

  • Immunocytochemical markers in stage I lung cancer: relevance to prognosis.

    Ugo Pastorino;Salvatore Andreola;Elda Tagliabue;Francesco Pezzella

  • Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth

    N. Normanno;M. Campiglio;A. De Luca;G. Somenzi

  • Prognostic significance of HER-2/NEU expression in breast cancer and its relationship to other prognostic factors

    F Rilke;M I Colnaghi;N Cascinelli;S Andreola

  • FOXP3 Expression and Overall Survival in Breast Cancer

    Andrea Merlo;Patrizia Casalini;Maria Luisa Carcangiu;Chiara Malventano

  • Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

    Sylvie Mènard;Elda Tagliabue;Silvana Canevari;Giuseppe Fossati

  • HER2 as a prognostic factor in breast cancer.

    Sylvie Ménard;Stefania Fortis;Fabio Castiglioni;Roberto Agresti

  • N-(4-Hydroxyphenyl)retinamide Induces Apoptosis of Malignant Hemopoietic Cell Lines Including Those Unresponsive to Retinoic Acid

    Domenico Delia;Antonella Aiello;Luciano Lombardi;Pier Giuseppe Pelicci

Frequent Co-Authors

Maria I. Colnaghi
Maria I. Colnaghi University of Milan
Elda Tagliabue
Elda Tagliabue Fondazione IRCCS Istituto Nazionale dei Tumori
Andrea Balsari
Andrea Balsari University of Milan
Silvana Canevari
Silvana Canevari University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan
Vincent Castronovo
Vincent Castronovo University of Liège
Marco A. Pierotti
Marco A. Pierotti University of Bari Aldo Moro
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Mario P. Colombo
Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori
Jeanette A.M. Maier
Jeanette A.M. Maier University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in alternative or complementary paths to a traditional medical degree in the USA? There are a variety of in-demand online degrees and career pathways that cater to diverse interests within healthcare.

rn to np bridge programs offer experienced registered nurses a fast-track route to become nurse practitioners through flexible online study. Similarly, if you’re seeking advancement without extensive on-campus requirements, online rn to bsn programs no clinicals provide a convenient, career-boosting option for RNs.

For those interested in the intersection of health, science, and nutrition, online nutrition degrees allow students to specialize in dietary science and wellness entirely through digital platforms.

Additionally, aspiring healthcare administrators can earn respected credentials with cahme accredited online mha programs, ensuring their qualifications meet the highest standards for leadership roles.

These flexible, accredited programs open numerous doors in clinical, administrative, and nutrition-related fields, providing a practical path into healthcare outside of medical school.

Best Scientists Citing Sylvie Ménard

Trending Scientists

Recently Published Articles